Tenax Therapeutics (TENX) Competitors $4.49 +0.10 (+2.28%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends TENX vs. BASI, VRCA, CDTX, BRNS, KRON, VOR, CVM, IMNN, THTX, and IMRXShould you be buying Tenax Therapeutics stock or one of its competitors? The main competitors of Tenax Therapeutics include Bioanalytical Systems (BASI), Verrica Pharmaceuticals (VRCA), Cidara Therapeutics (CDTX), Barinthus Biotherapeutics (BRNS), Kronos Bio (KRON), Vor Biopharma (VOR), CEL-SCI (CVM), Imunon (IMNN), Theratechnologies (THTX), and Immuneering (IMRX). These companies are all part of the "medical" sector. Tenax Therapeutics vs. Bioanalytical Systems Verrica Pharmaceuticals Cidara Therapeutics Barinthus Biotherapeutics Kronos Bio Vor Biopharma CEL-SCI Imunon Theratechnologies Immuneering Bioanalytical Systems (NASDAQ:BASI) and Tenax Therapeutics (NASDAQ:TENX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, valuation, risk, earnings, profitability, institutional ownership, analyst recommendations and community ranking. Which has more risk & volatility, BASI or TENX? Bioanalytical Systems has a beta of 1.92, suggesting that its stock price is 92% more volatile than the S&P 500. Comparatively, Tenax Therapeutics has a beta of 2.22, suggesting that its stock price is 122% more volatile than the S&P 500. Do institutionals & insiders hold more shares of BASI or TENX? 10.6% of Bioanalytical Systems shares are held by institutional investors. Comparatively, 1.7% of Tenax Therapeutics shares are held by institutional investors. 11.5% of Bioanalytical Systems shares are held by insiders. Comparatively, 3.7% of Tenax Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community favor BASI or TENX? Tenax Therapeutics received 16 more outperform votes than Bioanalytical Systems when rated by MarketBeat users. Likewise, 56.03% of users gave Tenax Therapeutics an outperform vote while only 38.91% of users gave Bioanalytical Systems an outperform vote. CompanyUnderperformOutperformBioanalytical SystemsOutperform Votes12838.91% Underperform Votes20161.09% Tenax TherapeuticsOutperform Votes14456.03% Underperform Votes11343.97% Which has better valuation & earnings, BASI or TENX? Bioanalytical Systems has higher revenue and earnings than Tenax Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioanalytical Systems$60.47M0.33-$4.68M-$0.35-5.09Tenax TherapeuticsN/AN/A-$7.71MN/AN/A Do analysts prefer BASI or TENX? Tenax Therapeutics has a consensus price target of $170.67, suggesting a potential upside of 3,701.04%. Given Tenax Therapeutics' higher probable upside, analysts plainly believe Tenax Therapeutics is more favorable than Bioanalytical Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bioanalytical Systems 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ATenax Therapeutics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20 Is BASI or TENX more profitable? Tenax Therapeutics has a net margin of 0.00% compared to Bioanalytical Systems' net margin of -7.75%. Bioanalytical Systems' return on equity of -42.74% beat Tenax Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Bioanalytical Systems-7.75% -42.74% -6.38% Tenax Therapeutics N/A -123.60%-103.37% Does the media prefer BASI or TENX? In the previous week, Tenax Therapeutics had 9 more articles in the media than Bioanalytical Systems. MarketBeat recorded 9 mentions for Tenax Therapeutics and 0 mentions for Bioanalytical Systems. Tenax Therapeutics' average media sentiment score of 0.63 beat Bioanalytical Systems' score of 0.00 indicating that Tenax Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment Bioanalytical Systems Neutral Tenax Therapeutics Positive SummaryTenax Therapeutics beats Bioanalytical Systems on 9 of the 15 factors compared between the two stocks. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Get Tenax Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TENX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TENX vs. The Competition Export to ExcelMetricTenax TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$15.31M$7.02B$5.32B$8.52BDividend YieldN/A7.92%5.07%4.13%P/E RatioN/A12.25127.5316.08Price / SalesN/A396.061,490.6892.20Price / CashN/A47.4339.5134.18Price / Book0.175.604.765.07Net Income-$7.71M$153.56M$118.77M$225.46M7 Day Performance-5.47%-1.46%-0.38%0.06%1 Month Performance32.06%15.32%6.06%3.93%1 Year Performance-69.68%43.07%38.14%32.50% Tenax Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TENXTenax Therapeutics3.2034 of 5 stars$4.49+2.3%$170.67+3,705.3%-69.7%$15.29MN/A0.009News CoverageBASIBioanalytical SystemsN/A$1.77-2.7%N/A-4.8%$19.70M$60.47M-4.21397Analyst ForecastVRCAVerrica Pharmaceuticals4.1939 of 5 stars$1.40-12.5%$11.40+714.3%-58.1%$59.39M$13.91M-0.7440CDTXCidara Therapeutics4.2841 of 5 stars$13.00+1.3%$29.67+128.2%-18.5%$59.31M$53.87M-0.5290Upcoming EarningsNews CoverageBRNSBarinthus Biotherapeutics3.487 of 5 stars$1.49+4.2%$5.83+291.5%N/A$58.73M$800,000.00-0.90107Short Interest ↓News CoverageKRONKronos Bio3.5664 of 5 stars$0.97+3.2%$4.13+325.3%+17.4%$58.49M$8.41M-0.56100Short Interest ↓News CoverageVORVor Biopharma1.6508 of 5 stars$0.84+5.0%$10.92+1,199.9%-51.4%$57.44MN/A-0.48140Upcoming EarningsNews CoverageHigh Trading VolumeCVMCEL-SCIN/A$0.90flatN/A-47.5%$57.28MN/A-1.5543IMNNImunon3.3947 of 5 stars$0.93-3.1%$14.00+1,405.4%-2.4%$55.85M$500,000.00-0.4833Upcoming EarningsNews CoverageGap UpTHTXTheratechnologiesN/A$1.21-3.2%N/A+37.1%$55.64M$84.32M-12.10140IMRXImmuneering3.7837 of 5 stars$1.86-3.1%$12.60+577.4%-71.1%$55.16M$320,000.00-0.9760Short Interest ↓News CoveragePositive News Related Companies and Tools Related Companies Bioanalytical Systems Alternatives Verrica Pharmaceuticals Alternatives Cidara Therapeutics Alternatives Barinthus Biotherapeutics Alternatives Kronos Bio Alternatives Vor Biopharma Alternatives CEL-SCI Alternatives Imunon Alternatives Theratechnologies Alternatives Immuneering Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TENX) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tenax Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tenax Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
